Katrina M. Mennie

Katrina M. Mennie

Auto-generated profile, based on publicly available information

Katrina M. Mennie

Merck & Co., Inc., Boston, Massachusetts 02115, United States

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2020 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
HSHayden A. Sharma
Hayden A. Sharma
KMKatrina M. Mennie
Katrina M. Mennie
EKEugene E. Kwan
Eugene E. Kwan
EJEric N. Jacobsen
Eric N. Jacobsen

26 May 2021 in Organic Letters
Verified
Journal Article
Closed access
KMKatrina M. Mennie
Katrina M. Mennie
MRMichael H. Reutershan
Michael H. Reutershan
CWCatherine White
Catherine White
BABruce Adams
Bruce Adams
BBBridget Becker
Bridget Becker
JSJosep Saurí
Josep Saurí

30 July 2020 in ChemRxiv
Verified
Preprint
Open access
HSHayden Sharma
Hayden Sharma
KMKatrina Mennie
Katrina Mennie
EKEugene Kwan
Eugene Kwan
EJEric Jacobsen
Eric Jacobsen
We report a strategy for effecting catalytic, enantioselective carbocationic rearrangements through the intermediacy of alkyl iodanes as stereodefined carbocation equivalents. Asymmetric Wagner–Meerwein rearrangements of β-substituted styrenes are catalyzed by the C2-symmetric aryl iodide 1 to provide access to enantioenriched 1,3-difluorinated molecules possessing interesting and well-defined conformational properties. Hammett and kinetic isotope effect studies, in combination with computational investigations, reveal that two different mechanisms are operative in these rearrangement reactions, with the pathway depending on the identity of the migrating group. In reactions involving alkyl-group migration, intermolecular fluoride attack is product- and enantio-determining. In contrast, reactions in which aryl rearrangement occurs proceed through an enantiodetermining intramolecular 1,2-migration prior to fluorination. The fact that both pathways are promoted by the same chiral aryl iodide catalyst with high enantioselectivity provides a compelling illustration of generality across reaction mechanisms in asymmetric catalysis.